Skip to content

The effect of ketamine and methadon on healthy volunteers with special focus on painscore, sedation, ventilatory depression and change of pupil diameter.

Effect of u opioid receptor (MOR) versus N-methyl-D- aspartate(NMDAR) receptor involvement in ketamine and methadone effects in healthy volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20544
Enrollment
48
Registered
2009-09-30
Start date
2010-01-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

analgesia respiratory depression pijnstilling analgesie ademhalingsdepressie

Interventions

There are 2 separate studies. Study A,in which the subject will receive a 80 min infusion of S(+) ketamine and Study B in which the subject will receive iv methadone. Each study has 2 legs, a respira

Sponsors

Leiden University Medical Centre (LUMC)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 48 healthy volunteers of either sex in the range op 18-45 years.

Exclusion criteria

Exclusion criteria: 1. Obesity (BMI>35); 2. Presence of medical disease (heart-,lung-, liver-,kidney-, neurologic disease,diabetes m, pyrosis,diaphragmatic hernia); 3. Presence of psychiatric disease; 4. History of chronic alcohol or illicit drug use; 5. Allergy to study medications; 6. For females we require the use of oral contraceptives.

Design outcomes

Primary

MeasureTime frame
Little is known on the relative contribution of NMDARand u-opioid receptor systhems in the analgesic and side effect profile of methadone and ketamine, therefore we measure respiration, sedationscore (Visual Analog Score), painscore (Visual Analogue Score) and pupildiameter (pupillometry).

Contacts

Public ContactAlbert Dahan

Leiden University Medical Center (LUMC), Department of Anesthesiology, P.O. Box 9600

a.dahan@lumc.nl+31 (0)71 5262301

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)